Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post COVID-19 Acute Mucormycosis in Critical Care Settings in Egypt: A Single-Center Experience

NCT05911035 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05911035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05911035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post COVID-19 Acute Mucormycosis in Critical Care Settings in Egypt: A Single-Center Experience
Lead sponsor
Zagazig University
Phase
Observational
Overall status
Completed
Start date
May 1, 2021
Completion date
May 1, 2023
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mucormycosis; rhinocerebral (etiology), post covid-19 condition, unspecified